Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Lizzo had earlier revealed she had lowered her body mass index (BMI) by 10.5 and lost 16% of her body fat since January 2023.

As demand grows for non-surgical aesthetic procedures, Mansfield Cosmetic Surgery Center has released a comprehensive new ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

Tammy Slaton's weight loss journey in recent seasons of 1000-Lb Sisters has been truly remarkable, as she has reached her ...

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...

Self-esteem scores jumped a remarkable 131% within just one year of bariatric surgery, according to a large study presented ...

Weight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

A new study suggests that popular weight loss medications could significantly benefit patients awaiting kidney transplants.

Self-esteem scores more than doubled within one year of weight-loss surgery, according to a new study presented today at the ...